Bay Street News, 2024

TEL AVIV, Israel, April 11, 2024 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical […]

FREMONT, Calif., April 11, 2024 (GLOBE NEWSWIRE) — Complete Solaria, Inc. (“Complete Solaria” or the “Company”) (Nasdaq: CSLR) today reported […]

The annual conference for U.S. and international special operations forces is expected to host more than 15,000 attendees Rehovot, Israel, […]

The Company’s neurodegenerative clinical program remains on track, with continued advancement of the Alzheimer’s Phase 2 trial and anticipation of […]

DUBLIN, Ireland and MILAN, Italy, April 11, 2024 (GLOBE NEWSWIRE) — Brera Holdings PLC (“Brera Holdings”, “Brera” or the “Company”) […]

Analysis of eligible1 patients from the sepsis Phase II study (NCT# NCT04612413) In accordance with the study protocol, the safety and […]

Successful completion of TVGN 489’s proof-of-concept clinical trial suggested the ability to target and eliminate a virus in high-risk population […]

LITTLE ROCK, Ark., April 11, 2024 (GLOBE NEWSWIRE) — Uniti Group Inc. (“Uniti” or the “Company”) (Nasdaq: UNIT) announced today […]

CALGARY, Alberta, April 11, 2024 (GLOBE NEWSWIRE) — Parex Resources Inc. (“Parex” or the “Company”) (TSX: PXT) and its strategic […]

SANTA BARBARA, Calif., April 11, 2024 (GLOBE NEWSWIRE) — AppFolio, Inc. (NASDAQ: APPF) today announced that it will report its […]